# FDA Inspection 1261674 - Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant) - March 14, 2025

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-kangle-pharmaceutical-co-ltd-binhai-plant/5579cf2d-3b5f-4fa4-8f41-f00c9cdad9cb
Source feed: FDA_Inspections

> FDA Inspection 1261674 for Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant) on March 14, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1261674
- Company Name: Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)
- Inspection Date: 2025-03-14
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1261674 - 2025-03-14](https://www.keypedia.com/records/fda_inspections/zhejiang-kangle-pharmaceutical-co-ltd-binhai-plant/c4db414c-686b-4498-a4b8-2022ce9c30ef)
- [FDA Inspection 1084107 - 2019-03-22](https://www.keypedia.com/records/fda_inspections/zhejiang-kangle-pharmaceutical-co-ltd-binhai-plant/98b9736f-c6d4-4c5c-9113-69846725a990)
- [FDA Inspection 981968 - 2016-07-22](https://www.keypedia.com/records/fda_inspections/zhejiang-kangle-pharmaceutical-co-ltd-binhai-plant/8b97ae07-4a88-400a-b547-8a2b7e519a2a)
- [FDA Inspection 866095 - 2013-12-20](https://www.keypedia.com/records/fda_inspections/zhejiang-kangle-pharmaceutical-co-ltd-binhai-plant/bdf2219a-f288-4681-afc4-a73a83866128)
- [FDA Inspection 582495 - 2009-04-23](https://www.keypedia.com/records/fda_inspections/zhejiang-kangle-pharmaceutical-co-ltd-binhai-plant/1db12960-7163-4efe-a4cf-9fe5bd3e19fb)

Company: https://www.keypedia.com/companies/zhejiang-kangle-pharmaceutical-co-ltd-binhai-plant/13be9174-238f-43cf-bdf4-0c57cc0b0bc2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c